Free press releases distribution network?

Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



AnaSpec Introduces 51 New Apoptosis-Related Antibodies - Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added fifty-one (51) new antibodies to its growing collection of catalog antibodies
AnaSpec Introduces 51 New Apoptosis-Related Antibodies

 

PRZOOM - /newswire/ - San Jose, CA, United States, 2007/04/10 - Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added fifty-one (51) new antibodies to its growing collection of catalog antibodies.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The targeted researchers area for these antibodies is apoptosis.

Anti-ADAM10 (CT) KUZ; MADM - Cat# 28071, 50 g

Anti-Bax - Cat# 53252, 50 g

Anti-Bcl-2 (pThr129) - Cat# 29658, 50 g

Anti-Bcl-2alpha - Cat# 53256, 50 g

Anti-Bcl-2alpha - Cat# 53257, 50 g

Anti-Bcl-X - Cat# 53260, 50 g

Anti-bcl-X - Cat# 53261, 50 g

Anti-Bcl-xL - Cat# 53262, 50 g

Anti-bcl-XL - Cat# 53263, 50 g

Anti-Bim - Cat# 53265, 50 g

Anti-BRCA1 - Cat# 53272, 50 g

Anti-BRCA2 - Cat# 53273, 50 g

Anti-Caspase-8L - Cat# 29625, 50 g

Anti-MADD - Cat# 53623, 50 g
MAP-kinase-Activating Death Domain protein

Anti-MAGE (IN) - Cat# 28004, 50 g

Anti-Mammaglobin - Cat# 53625, 50 g

Anti-Mcl-1 - Cat# 53628, 50 g
Myeloid cell leukemia-1

Anti-MDM2 - Cat# 53631, 50 g

Anti-MGMT - Cat# 53644, 50 g
methylguanine-DNA methyltransferase

Anti-MLH1 - Cat# 53665, 50 g

Anti-MMF-4/Myogenin - Cat# 53666, 50 g

Anti-MMP-1 (COLLAGENASE-1) - Cat# 53667, 50 g

Anti-MMP-1 (NT) - Cat# 29574, 50 g
Collagenase-1; Interstitial Collagenase

Anti-MMP-10 (Stromilysin-2) - Cat# 53668, 50 g
Matrix MetalloProteinases-10

Anti-MMP-11 (Stromelysin-3) - Cat# 53669, 50 g

Anti-MMP-13 (Collagenase-3) - Cat# 53670, 50 g

Anti-MMP-14 - Cat# 53671, 50 g

Anti-MMP-15 - Cat# 53672, 50 g

Anti-MMP-19 - Cat# 53673, 50 g

Anti-MMP-2 - Cat# 29575, 50 g
Gelatinase A

Anti-MMP-2 (72 kDa Collagenase IV) - Cat# 53674, 50 g

Anti-MMP-23 - Cat# 53675, 50 g

Anti-MMP-3 (NT) - Cat# 29576, 50 g
Stromelysin-1

Anti-MMP-3 (Stromelysin-1) - Cat# 53676, 50 g

Anti-MMP-7 (Matrilysin) - Cat# 53677, 50 g

Anti-MMP8 (hinge) - Cat# 29578, 50 g
Collagenase 2; Neutrophil Collagenase

Anti-p14ARF - Cat# 53733, 50 g

Anti-p16INK4a - Cat# 53735, 50 g

Anti-p27Kip1 - Cat# 53744, 50 g

Anti-p504S/ AMACR - Cat# 53747, 50 g

Anti-p57Kip2 - Cat# 53752, 50 g

Anti-p63 - Cat# 53753, 50 g

Anti-PARP - Cat# 53761, 50 g

Anti-Prohibitin - Cat# 53796, 50 g

Anti-Prostate Apoptosis Response Protein-4 - Cat# 53800, 50 g

Anti-PTEN (pSer385) - Cat# 29642, 50 g

Anti-Retinoblastoma - Cat# 53823, 50 g

Anti-TGase II - Cat# 53892, 50 g

Anti-TRADD - Cat# 53921, 50 g

Anti-Ube1L - Cat# 53933, 50 g

Anti-von Hippel-Lindau Protein - Cat# 53948, 50 g

About AnaSpec, Inc.
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry. Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces 51 New Apoptosis-Related Antibodies

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Ping 
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First European Patients Treated with DC Bead LUMI Radiopaque Drug-Eluting Beads
FDA Approves Genentechs Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today